Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat

Experimental Neurology

Volumn 168, Issue 1, 2001, Pages 144-154

  Plunkett, Jeffery A ^a,b   Yu, Chen Guang ^a   Easton, Julia M ^a   Bethea, John R ^a,b   Yezierski, Robert P ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; FAS LIGAND; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE SYNTHASE; QUISQUALIC ACID;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; GENE EXPRESSION; INFLAMMATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; WESTERN BLOTTING;

EID: 0035126792     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7604     Document Type: Article

References (47)

1. Attenuation of astroglial reactivity by interleukin-10
2. A peripherial mononeuropathy in rat that produces disorders of pain sensation like those seen in man
3. Post-spinal cord injury pain states
4. Inhibition of macrophage inflammatory protein-I expression by IL-10
5. Traumatic spinal cord injury induces nuclear factor KAPPA-B activation
6. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
7. Effects of interleukin-10 (IL-10) on pain behaviors following excitotoxic spinal cord injury
8. Macrophages and inflammatory damage in spinal cord injury
9. Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage
10. Neuroprotective effects of interleukin-10 following spinal cord injury
11. Mechanical and thermal allodynia in chronic central pain following spinal cord injury
12. Staphylococcal enterotoxin B and tumor-necrosis factor-α induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factors and interleukin-10
13. Morphological characterization of excitotoxic injury in the rat spinal cord
14. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
15. Regulation of manganese superoxide dismutase and inducible nitric oxide synthase during spinal cord injury
16. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury
17. A potential role for excitotoxins in the pathophysiology of spinal cord injury
18. IL-10 inhibits cytokine production by activated macrophages
19. Antigen presentation in the central nervous system: The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed
20. Excitotoxic spinal cord injury: Influence of strain, gender and extent of injury on a spontaneous pain-like behavior in the rat
21. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease
22. Involvement for excitatory amino acids and peptides in the spinal mechanisms underlying hyperalgesia
23. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β
24. Determination of DNA and RNA in homogenized cells and tissues by surface fluorometry
25. Cytokines and inflammation in the central nervous system
26. Cytokine involvement in dynorphin-induced allodynia
27. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord
28. Transient spinal ischemia in rat: Characterization of spinal cord blood flow, extracellular amino acid release and concurrent histopathological damage
29. CD95 (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemic-induced apoptosis in neurons
30. Nitric oxide (NO) and nociceptive processing in the spinal cord
31. HIV-1 macrophages, glial cells and cytokines in AIDS nervous system brain
32. Chronic, selective forebrain responses to excitotoxic dorsal horn injury
33. Cyclooxygenase-2 expression in neurons contributes to ischemic brain damage
34. Cellular inflammatory response after spinal cord injury in Spragu-Dawley and Lewis rats
35. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis
36. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis
37. Reactive microgliosis
38. Electronic imaging system for direct and rapid quantitation of fluorescence from electrophoretic gels: Application to ethidium bromide-stained DNA
39. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
40. Anti-inflammatory interleukin-10 in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-α expression
41. Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat
42. Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneuronal tissues
43. The mechanosensitivity of spinal neurons following intraspinal injections of quisqualic acid in the rat
44. Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat
45. Pain following spinal cord injury: The clinical problem and experimental studies
46. Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat
47. Behavioral and pathological characteristics of a central pain model following spinal injury